Biopsychosocial response to the COVID-19 lockdown in people with major depressive disorder and multiple sclerosis
View ORCID ProfileS Siddi, I Giné-Vázquez, R Bailon, F Matcham, F Lamers, S Kontaxis, E Laporta, E Garcia, View ORCID ProfileB Arranz, G Dalla Costa, A.I Guerrero Pérez, View ORCID ProfileA. Zabalza, View ORCID ProfileM Buron, View ORCID ProfileG Comi, View ORCID ProfileL. Leocani, P Annas, View ORCID ProfileM Hotopf, View ORCID ProfileBWJH Penninx, View ORCID ProfileM Magyari, View ORCID ProfileP. S. Sørensen, View ORCID ProfileX Montalban, G Lavelle, A Ivan, C Oetzmann, M K White, S Difrancesco, P Locatelli, DC Mohr, J Aguiló, V Narayan, A Folarin, R Dobson, J Dineley, View ORCID ProfileD Leightley, View ORCID ProfileN Cummins, S Vairavan, Y Ranjan, Z Rashid, View ORCID ProfileA Rintala, View ORCID ProfileG De Girolamo, View ORCID ProfileA Preti, View ORCID ProfileS Simblett, View ORCID ProfileT Wykes, PAB members, View ORCID ProfileI Myin-Germeys, View ORCID ProfileJM Haro the RADAR-CNS consortium
doi: https://doi.org/10.1101/2022.05.10.22274890
S Siddi
1Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain
I Giné-Vázquez
1Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain
R Bailon
2Aragón Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain
3Centros de investigación biomédica en red en el área de bioingeniería, biomateriales y nanomedicina (CIBER-BBN), Madrid, Spain
F Matcham
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
5School of Psychology, University of Sussex, East Sussex
F Lamers
6Amsterdam UMC, Vrije Universiteit, Department of Psychiatry
7Amsterdam Public Health research institute, the Netherlands
S Kontaxis
2Aragón Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain
3Centros de investigación biomédica en red en el área de bioingeniería, biomateriales y nanomedicina (CIBER-BBN), Madrid, Spain
E Laporta
3Centros de investigación biomédica en red en el área de bioingeniería, biomateriales y nanomedicina (CIBER-BBN), Madrid, Spain
E Garcia
3Centros de investigación biomédica en red en el área de bioingeniería, biomateriales y nanomedicina (CIBER-BBN), Madrid, Spain
8Microelectrónica y Sistemas Electrónicos, Universidad Autónoma de Barcelona, Spain
B Arranz
1Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain
G Dalla Costa
9Institute of Experimental Neurology, Istituto Di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy
A.I Guerrero Pérez
10Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology/Neuroimmunology, Vall d’Hebron Institut de Recerca, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
A. Zabalza
10Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology/Neuroimmunology, Vall d’Hebron Institut de Recerca, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
M Buron
11Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
G Comi
9Institute of Experimental Neurology, Istituto Di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy
L. Leocani
9Institute of Experimental Neurology, Istituto Di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy
12Cura Policlinico, Milan, Italy
P Annas
13H. Lundbeck A/S, Valby, Denmark
M Hotopf
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
BWJH Penninx
6Amsterdam UMC, Vrije Universiteit, Department of Psychiatry
7Amsterdam Public Health research institute, the Netherlands
M Magyari
11Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
P. S. Sørensen
11Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
X Montalban
10Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology/Neuroimmunology, Vall d’Hebron Institut de Recerca, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
G Lavelle
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
A Ivan
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
C Oetzmann
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
M K White
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
S Difrancesco
6Amsterdam UMC, Vrije Universiteit, Department of Psychiatry
P Locatelli
14Department of Engineering and Applied Scienc, Bergamo, Italy
DC Mohr
15Center for Behavioral Intervention Technologies, Department of Preventative Medicine, Northwestern University, Chicago, IL, USA
J Aguiló
3Centros de investigación biomédica en red en el área de bioingeniería, biomateriales y nanomedicina (CIBER-BBN), Madrid, Spain
8Microelectrónica y Sistemas Electrónicos, Universidad Autónoma de Barcelona, Spain
V Narayan
16Research and Development Information Technology, Janssen Research & Development, LLC, Titusville, NJ, United States
A Folarin
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
R Dobson
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
J Dineley
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
D Leightley
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
N Cummins
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
S Vairavan
16Research and Development Information Technology, Janssen Research & Development, LLC, Titusville, NJ, United States
Y Ranjan
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
Z Rashid
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
A Rintala
17Department for Neurosciences, Center for Contextual Psychiatry, Katholieke Universiteit Leuven, Leuven, Belgium
18Faculty of Social Services and Health Care, LAB University of Applied Sciences, Lahti, Finland
G De Girolamo
19IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
A Preti
20Dipartimento di neuroscienze, Università degli studi di Torino, Italia
S Simblett
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
T Wykes
4King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK
I Myin-Germeys
17Department for Neurosciences, Center for Contextual Psychiatry, Katholieke Universiteit Leuven, Leuven, Belgium
JM Haro
1Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain
Data Availability
All data produced in the present work are contained in the manuscript
Posted May 10, 2022.
Biopsychosocial response to the COVID-19 lockdown in people with major depressive disorder and multiple sclerosis
S Siddi, I Giné-Vázquez, R Bailon, F Matcham, F Lamers, S Kontaxis, E Laporta, E Garcia, B Arranz, G Dalla Costa, A.I Guerrero Pérez, A. Zabalza, M Buron, G Comi, L. Leocani, P Annas, M Hotopf, BWJH Penninx, M Magyari, P. S. Sørensen, X Montalban, G Lavelle, A Ivan, C Oetzmann, M K White, S Difrancesco, P Locatelli, DC Mohr, J Aguiló, V Narayan, A Folarin, R Dobson, J Dineley, D Leightley, N Cummins, S Vairavan, Y Ranjan, Z Rashid, A Rintala, G De Girolamo, A Preti, S Simblett, T Wykes, PAB members, I Myin-Germeys, JM Haro
medRxiv 2022.05.10.22274890; doi: https://doi.org/10.1101/2022.05.10.22274890
Biopsychosocial response to the COVID-19 lockdown in people with major depressive disorder and multiple sclerosis
S Siddi, I Giné-Vázquez, R Bailon, F Matcham, F Lamers, S Kontaxis, E Laporta, E Garcia, B Arranz, G Dalla Costa, A.I Guerrero Pérez, A. Zabalza, M Buron, G Comi, L. Leocani, P Annas, M Hotopf, BWJH Penninx, M Magyari, P. S. Sørensen, X Montalban, G Lavelle, A Ivan, C Oetzmann, M K White, S Difrancesco, P Locatelli, DC Mohr, J Aguiló, V Narayan, A Folarin, R Dobson, J Dineley, D Leightley, N Cummins, S Vairavan, Y Ranjan, Z Rashid, A Rintala, G De Girolamo, A Preti, S Simblett, T Wykes, PAB members, I Myin-Germeys, JM Haro
medRxiv 2022.05.10.22274890; doi: https://doi.org/10.1101/2022.05.10.22274890
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2852)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12560)
- Forensic Medicine (10)
- Gastroenterology (806)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (401)
- Health Economics (716)
- Health Informatics (2850)
- Health Policy (1048)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (462)
- Neurology (4193)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (483)
- Public and Global Health (6782)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (201)
- Urology (174)